exemption for corporate income tax under the BOI privileges, therefore, the dividend is not subject to withholding tax in Thailand, in which the dividend payment will be subject to shareholder approval. The
Meeting of the Shareholder No.1/2019 on March 18, 2019 approved the Company and the subsidiary to settle the disputes with EXAT as described in No.1. It is pending to the EXAT proceeding according to the
Total Shareholder Equity 2018 Q1 2019 Unit: THB mm Liabilities As of 31 March 2019, the Company had total liabilities of THB 44,795.5 mm, which decreased by THB 2,535.4 mm from THB 47,330.9 mm as of 31
liabilities have decreased as the Saraburi Acquisition loan and the Hua-Pha-Way Kiln 7 loan continue to be repaid. Shareholder equity increased in-line with the additional net result. Balance Sheet Summary as
Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. Shareholder name Before Acquisition After Acquisition 1. Bangjak Green Energy Company Limited 399,990 shares
Million. o Dividend payment of 2018 (April – December) to shareholders whose names appear in the shareholder register as of March 13, 2019 for 280 Million shares at 0.10 Baht per share. Totaling of Baht
Receipt) for the purchase of fuel in H1. Non-current liabilities have decreased as the Saraburi Acquisition loan and the Hua-Pha-Way Kiln 7 loan continue to be repaid. Shareholder equity reduced with the
shareholder at Annual General Meeting resolved to approve the cash dividend payment from the operating results of 2H 2017 at THB 0.018 per share (a total of THB 62mn). The total dividend payment from 2017
in long-term liabilities due to the 330mTHB term loan used to acquire Saraburi Quicklime impacted total liabilities. Shareholder equity increased in-line with the additional net result. Balance Sheet
related to the Company since its authorized directors and major shareholders are Kewkacha family who is also the major shareholder and director of the Company as detail below; Related Person Relationship